期刊文献+

乳腺基底(细胞)样导管原位癌1例

下载PDF
导出
摘要 患者59岁,自觉乳腺疼痛6年余,无乳头红肿及乳头溢液。就诊于当地医院,诊断为“乳腺增生”,患者末予重视,末正规治疗。近3天自觉乳腺疼痛加重,伴针刺感,
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2013年第11期1268-1269,共2页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献9

  • 1丁华野,皋岚湘.乳腺导管原位癌的病理诊断[J].诊断病理学杂志,2003,10(1):5-7. 被引量:17
  • 2Vincent-Satomon A, Lucehesi C, Gruel N, et al. Integrated ge- nomie and transcriptomic analysis of ductal carcinoma in situ of the breast [ J ]. Clin Cancer Res, 2008,14 (7) : 1956 - 65.
  • 3Bryan B B, Schnitt S J, Collins L C, et al. Duetal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer[ J]. Mod Pathol, 2006,19(5 ) :617 -21.
  • 4Livasy C A, Perou C M, Karaca G, et al. Identification of a bas- al-like subtype of breast ductal carcinoma in situ [ J ]. Hum Pathol, 2007,38 ( 2 ) : 197 - 204.
  • 5Dabbs D J, Chivukula M, Carter G, et al. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile [ J]. Mod Pathol, 2006,19( 11 ) : 1506 - 11.
  • 6Paredes J, Lopes N, Milanezi F, et al. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcino- mas in situ[ J]. Virchows Archly, 2007,450 (1) :73 -80.
  • 7Tamimi R M, Baer H J, Marotti J, et al. Cmnparison of molecular phenotypes of ductal carcinoma in situ and invasive breasl cancer [J]. Breast Cancer Res, 2008,10(4):R67.
  • 8郎志强,魏兵,步宏,张红英,李新军,陈卉娇.基底型细胞角蛋白在乳腺导管内增生性病变诊断中的应用[J].临床与实验病理学杂志,2006,22(1):19-23. 被引量:16
  • 9Meijnen P. Peterse J L, Antonini N, et al. hmnunohistoehemical categorisation of duetal carcinoma in situ of Ihe breast [ J ]. Br J Cancer, 2008,98( 1 ) : 137 -42.

二级参考文献23

  • 1魏兵,步宏,朱采蓉,郭立新,陈卉娇,赵春,章培,陈代云,唐颖,姜勇.交界性导管增生性乳腺病的病理诊断重复性研究[J].四川大学学报(医学版),2004,35(6):849-853. 被引量:4
  • 2龚西騟.乳腺活检中热点问题的新认识(一)[J].临床与实验病理学杂志,2005,21(1):1-5. 被引量:16
  • 3Boecker W,Moll R,Dervan P,et al.Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ[J].J Pathol,2002,198:458-467.
  • 4Clarke C L,Sandle J,Parry S C,et al.Cytokeratin 5/6 in normal human breast:lack of evidence for a stem cell phenotype[J].J Pathol,2004,204:147-152.
  • 5Reis-Filho J S,Schmidtt F C.Taking advantage of basic research:p63 is a reliable myoepithelial and stem cell marker[J].Adv Anat Pathol,2002,9:280-289.
  • 6Lacroix-Triki E,Merry E,Jean-Jacques V,et al.Value of cytokeratin5/6 immunostaining using D5/16B4 antibody in the spectrum of proliferative interepithelial lesions of the breast.A comparative study with CK34βE12 antibody[J].Virchows Arch,2003,442:548-554.
  • 7Jarasch E D,Nagle R B,Kaufmann M,et al.Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokerations[J].Hum Pathol,1988,19:276-289.
  • 8Wetzels R H W,Kuijpers H J H,Lane E B,et al.Basal cell-specific and hyperproliferation-related keratins in human breast cancer[J].Am J Pathol,1991,138:751-763.
  • 9Boecker W,Bier B,Freytag G,et al.An immunohistochemical study of the breast using antibodies to basal and luminal keratins,alpha-smooth muscle actin,vimentin,collagen Ⅳ,and laminin.PartⅠ:normal breast and benign proliferative lesions[J].Virchows Arch,1992,421:315-322.
  • 10Boecker W,Moll R,Poremba C,et al.Comman adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:a new cell biological concept[J].Lab Invest,2002,82:737-745.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部